Jasper Therapeutics Statistics
NASDAQ: JSPRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.56-0.0097 (-1.70%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Jasper Therapeutics by the numbers
Jasper Therapeutics has a market capitalization of $18.6 million based on 33.27M shares outstanding. With trailing EPS of $-1.04, Jasper Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.6% below its 50-day average and 41.1% below its 200-day average.
Average daily trading volume is 1.37M shares, or about $765,238 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
JSPR valuation vs. peer median
| Metric | JSPR | Peer median | Difference |
|---|---|---|---|
| Market cap | $18.63M | $16.93M | +10% |
| Avg. volume | 1.37M | 130.14K | +950% |
Peer median across 8 companies: ESLA, DYAI, SCLX, BCDA, TCRX, INAB, ATYR, PLUR.
Valuation
- Market cap
- $18.63M
- EPS (TTM)
- $-1.04
- Shares outstanding
- 33.27M
Price and trading
- Previous close
- 0.5697
- Open
- 0.5626
- Day range
- 0.5405 – 0.58
- 52-week range
- 0.315 – 2.69
- 52-week change
- -76.67%
- 50-day moving average
- 0.6719
- 200-day moving average
- 0.9512
- Beta
- —
- Volume
- 362.25K
- Average volume
- 1.37M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 18.63M
- Forward Pe
- -0.22
- Eps
- -1.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.69
- Week52 Low
- 0.32
- Avg Volume
- 1.37M
- Shares Outstanding
- 33.27M
- Ma50
- 0.67
- Ma200
- 0.95
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -79.18%
- Pct From52w Low
- 77.78%